Recalibrating the risks and benefits of lithium therapy
Michael Berk, Stephanie Cowdery, Lana Williams, Gin S Malhi
BRITISH JOURNAL OF PSYCHIATRY | ROYAL COLL PSYCHIATRISTS | Published : 2017
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.
Awarded by NHMRC Senior Principal Research Fellowship
Awarded by NHMRC Career Development Fellowship
This project was supported by a grant from Astra Zeneca. M.B is supported by an NHMRC Senior Principal Research Fellowship (No. 1059660). LW. is supported by an NHMRC Career Development Fellowship (GNT1064272).